MODULATION THERAPEUTIQUE POUR TRAITER LES ANOMALIES DE GLYCEMIE, Y COMPRIS LE DIABETE DE TYPE 2, ET/OU POUR REDUIRE LES NIVEAUX D'HBA1C, ET SYSTEMES ET METHODES ASSOCIES
Systems and methods for treating a patient having a blood glucose abnormality, such as type 2 diabetes (T2D), using an electrical signal are disclosed. A representative method for treating a patient includes, based at least in part on a patient indication of a blood glucose abnormality, positioning at least one implantable signal delivery device proximate to a target location at the patient's spinal cord within a vertebral range of from about C8 to about T12. The method further includes directing an electrical signal to the target location via the implantable signal delivery device, wherein the electrical signal has a frequency in a frequency range of from 1.2 kHz to 100 kHz.
